DealForma Research

Recent Articles

MedTech, Device, Digital Health and Wearables R&D, M&A, Ventures and IPOs – 2025 Review

April 1, 2026

Large-Cap Biopharma In-Licensing and Buying 2024 – Q2 2025

October 6, 2025

Large-Cap Biopharma M&A 2024-Q2 2025

September 30, 2025

Biopharma Therapeutics and Platform Deals by Modality 2024 – Q2 2025

September 22, 2025

Biopharma Therapeutics and Platforms 2024-Q2 2025

September 14, 2025

Neurology R&D Partnerships, M&A, Ventures and IPOs – H1 2025 Review

September 10, 2025

Cancer R&D Partnerships, M&A and Ventures – H1 2025 Review

September 2, 2025

Gene Therapy & Vectors R&D Partnerships, M&A and Venture Funding – H1 2025 Review

August 25, 2025

Autoimmune R&D Partnerships and M&A by Tech – H1 2025 Review

August 19, 2025

Biopharma Therapeutics and Platforms IPO Activity – Q2 2025 Review

August 11, 2025

Biopharma Therapeutics and Platforms Venture Funding – Q2 2025 Review

August 4, 2025

Biopharma Therapeutics and Platforms M&A – Q2 2025 Review

July 29, 2025

Biopharma Therapeutics and Platform R&D Partnerships – Q2 2025

July 25, 2025

All of this by stage, disease indication, modality, target…

+ 0 k

Licensing Deals

+ 0 k

M&A

+ 0 k

Other Deals

+ 0 k

Funding Rounds

+ 0 k

Company Profiles

+ 0 k

Drug Sales Figures